Fabtech Technologies Limited (FABTECH)

Loading page…

Fabtech Technologies Limited (FABTECH) · mywealthgrid

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Consolidated figures · ₹ crore

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	257	194	226	327	411
COGS	136	92	121	182	243
Gross profit	121	102	105	145	168
	89	80	71	107	133
	32	23	34	38	35
OPM %	12.5%	11.7%	15%	11.5%	8.6%
Depreciation	2	2	2	3	5
Interest	3	3	2	2	4
	3	6	4	27	22
Profit before tax	31	28	36	60	48
Tax	8	6	9	14	10
Tax %	25.2%	22.1%	23.9%	23.2%	20.6%
	23	22	27	46	38
PAT margin %	9.1%	11.2%	12%	14.2%	9.3%
EPS (₹)	—	—	—	—	10
EPS adjusted (₹)	—	—	—	—	8.6
	—	—	—	—	6%
Annual report	—	—	—	—	Annual report for Mar 2026

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	3	3	3	32	44
Reserves	65	86	129	141	375
	19	34	10	55	43
	86	91	127	199	191
Total equity & liabilities	172	214	269	427	654
	5	4	22	94	78
CWIP	—	—	—	—	—
Investments	17	20	21	15	26
	150	190	226	318	550
Total assets	172	214	269	427	654

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-3	-14	60	-36	0
	-9	2	-30	-20	-112
	8	12	-12	36	190
Net cash flow	-4	-0	18	-20	78
Free cash flow	—	—	—	—	-4
CFO / Operating profit %	-8.3%	-61.4%	178.3%	-95.9%	1.4%

Compounded sales growth

7 years: —
5 years: —
3 years: 29%
1 year: 26%

Compounded profit growth

7 years: —
5 years: —
3 years: 21%
1 year: -17%

Return on equity

7 years: —
5 years: 23%
3 years: 19%
Last year: 9%

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.

Source XBRL ↗

Latest reported period · 31 Mar 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities	Capital employed	ROCE %
Rest of the world	143.66	0	70.36	0	70.36	0
UAE	126.66	0	37.1

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	47%	52.7%	46.4%	44.4%	40.9%
EBITDA margin %	12.5%	11.7%	15%	11.5%	8.5%
EBIT margin %	11.9%	10.7%	14.1%	10.7%	7.2%
PAT margin %	9.1%	11.2%	12%	14.2%	9.3%
Working capital
Receivable days	120	187	156	168	182
Inventory days	17	69	88	119	32
Payable days	—	—	—	—	159
NWC days	—	—	—	—	55
Leverage
Current ratio	1.46	1.48	1.7	1.37	2.5
Debt to EBITDA	0.58	1.51	0.29	1.45	1.22
Debt to equity	0.28	0.39	0.07	0.32	0.1
Interest coverage	10.7	10.4	19.1	21.2	12.1
Asset turnover	1.5	0.91	0.84	0.77	0.63
Return ratios
Return on assets %	13.7%	10.2%	10.1%	10.9%	5.9%
Return on capital employed %	46.8%	33%	32.1%	26.4%	15.5%
Return on equity %	34.8%	24.4%	20.6%	26.8%	9.1%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	68.94%	68.94%	68.94%	68.94%
	1.91%	0.03%	0.08%	0.02%
	11.63%	1.99%	2.15%	2.45%
Government	0%	0%	0%	0%
	17.52%	29.04%	28.83%	28.59%
No. of shareholders	57,162	31,755	28,620	29,408

Loading shareholding…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 1 fund houses

Held by these funds

of the company's equity

All mutual funds

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

1 schemes

		Shares
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	329	0	0.01%	0.001%	-0

Loading fund holders…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

117 announcementsExport CSV

30 Sept 2026, 7:29 pmCompany Update

Announcement under Regulation 30 (LODR)-Restructuring

Restructuring PDF

17 Sept 2026, 1:18 pmCompany Update

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release / Media Release PDF

11 Sept 2026, 10:26 amCompany Update

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release / Media Release PDF

26 Aug 2026, 1:12 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

24 Aug 2026, 6:06 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Directorate

Change in Directorate PDF

24 Aug 2026, 4:58 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

AGM PDF

19 Aug 2026, 3:33 pmCompany Update

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release / Media Release PDF

3 Aug 2026, 5:25 pmCompany Update

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Earnings Call Transcript PDF

Date	Category	Subject	Filing
30 Sept 2026, 7:29 pm	Company Update Restructuring	Announcement under Regulation 30 (LODR)-Restructuring	PDF
17 Sept 2026, 1:18 pm	Company Update Press Release / Media Release	Announcement under Regulation 30 (LODR)-Press Release / Media Release

Loading announcements…

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	47%	52.7%	46.4%	44.4%	40.9%
EBITDA margin %	12.5%	11.7%	15%	11.5%	8.5%
EBIT margin %	11.9%	10.7%	14.1%	10.7%	7.2%
PAT margin %	9.1%	11.2%	12%	14.2%	9.3%
Working capital
Receivable days	120	187	156	168	182
Inventory days	17	69	88	119	32
Payable days	—	—	—	—	159
NWC days	—	—	—	—	55
Leverage
Current ratio	1.46	1.48	1.7	1.37	2.5
Debt to EBITDA	0.58	1.51	0.29	1.45	1.22
Debt to equity	0.28	0.39	0.07	0.32	0.1
Interest coverage	10.7	10.4	19.1	21.2	12.1
Asset turnover	1.5	0.91	0.84	0.77	0.63
Return ratios
Return on assets %	13.7%	10.2%	10.1%	10.9%	5.9%
Return on capital employed %	46.8%	33%	32.1%	26.4%	15.5%
Return on equity %	34.8%	24.4%	20.6%	26.8%	9.1%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Molbio Diagnostics LimitedMOLBIOMOLBIO	₹17,431 Cr	₹17,844 Cr	₹1,020 Cr	₹262 Cr	25.7%	₹145 Cr	13.6%	23.7%	16.2%	—
Poly Medicure LimitedPOLYMEDPOLYMED	₹16,610 Cr	₹16,952 Cr	₹1,997 Cr	₹461 Cr	23.6%	₹315 Cr	17.1%	14.5%	11%	294
Fischer Medical Ventures LimitedFISCHERFISCHER	₹2,190 Cr	₹2,262 Cr	₹367 Cr	₹50 Cr	14%	₹30 Cr	10.1%	13.6%	8.6%	111
Tarsons Products LimitedTARSONSTARSONS	₹1,752 Cr	₹2,135 Cr	₹441 Cr	₹119 Cr	27.9%	₹11 Cr	3.4%	5%	2.3%	361
Laxmi Dental LimitedLAXMIDENTLLAXMIDENTL	₹1,066 Cr	₹1,066 Cr	₹287 Cr	₹46 Cr	15.6%	₹31 Cr	10.4%	14.7%	12.8%	109
Hemant Surgical Industries LtdHSILHSIL	₹885 Cr	—	₹232 Cr	₹23 Cr	10%	₹18 Cr	7.9%	—	—	—
Fabtech Technologies LimitedFABTECHFABTECH	₹632 Cr	₹675 Cr	₹418 Cr	₹45 Cr	8.5%	₹49 Cr	9.3%	15.5%	12.9%	55
Prevest Denpro LtdPREVESTPREVEST	₹452 Cr	—	₹72 Cr	₹25 Cr	34.4%	₹20 Cr	28.5%	—	—	—
Nureca LimitedNURECANURECA	₹332 Cr	₹333 Cr	₹153 Cr	₹4 Cr	0.1%	₹4 Cr	1.4%	3.3%	1.1%	186
Earkart LtdEARKARTEARKART	₹179 Cr	₹179 Cr	₹54 Cr	₹8 Cr	15.5%	₹5 Cr	9.1%	12.1%	7.7%	243
Choksi Asia LtdCHOKSICHOKSI	₹117 Cr	₹119 Cr	₹11 Cr	₹-2 Cr	13.8%	₹2 Cr	10.8%	18.9%	13.5%	142
Shree Pacetronix LtdSHREEPACSHREEPAC	₹68 Cr	₹71 Cr	₹8 Cr	₹1 Cr	23.5%	₹0 Cr	14%	27.4%	18.9%	385

95 deals · 7 Oct 2025 – 16 Jun 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
16 Jun 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Sell	3,21,928	₹161.79	₹5.21 Cr
16 Jun 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Buy	3,21,928	₹161.65	₹5.20 Cr
28 Apr 2026	ARIHANT CAPITAL MARKETS LIMITED	Bulk	NSE	Sell	3,97,832	₹178.35	₹7.10 Cr
28 Apr 2026	ARIHANT CAPITAL MARKETS LIMITED	Bulk	NSE	Buy	3,97,832	₹177.93	₹7.08 Cr
28 Apr 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Sell	2,98,091	₹176.74	₹5.27 Cr
28 Apr 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Buy	2,98,091	₹176.64	₹5.27 Cr
27 Mar 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Buy	5,92,541	₹158.86	₹9.41 Cr
27 Mar 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Sell	5,92,541	₹158.97	₹9.42 Cr
27 Mar 2026	DHARMIK VITHTHALBHAI KAPURIYA	Bulk	NSE	Buy	2,68,554	₹158.75	₹4.26 Cr
27 Mar 2026	DHARMIK VITHTHALBHAI KAPURIYA	Bulk	NSE	Sell	2,68,554	₹158.87	₹4.27 Cr

1–10 of 95

1 / 10

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Fabtech Technologies Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Compounded sales growth

Compounded profit growth

Return on equity

Segment results

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

1

1

Announcements

1

1

Not in the F&O segment

Announcements

Annual reports

Offer and rights documents

Investor Presentation and earnings call

Compounded sales growth

Compounded profit growth

Return on equity

Segment results

Algeria · revenue

Fabtech Technologies Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Segment results

Ratios

Ratio timeline

Shareholding

Quarterly record

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

Dividends1

Board meetings1

Announcements

Ratio timeline

Dividends1

Board meetings1

Not in the F&O segment

Announcements

Quarterly record

Annual reports

Offer and rights documents

Investor Presentation and earnings call

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Segment results

Algeria · revenue

1

1

1

1